The role of level IV neck dissection in early tongue cancer

https://doi.org/10.53730/ijhs.v6nS3.6585

Authors

  • Himanshu Patidar Department of Surgical Oncology, Sri Aurobindo Medical College & PG Institute, Indore (M.P.
  • Mayank Pancholi Department of Surgical Oncology, Sri Aurobindo Medical College & PG Institute, Indore (M.P.)
  • Sanjay Desai Department of Surgical Oncology, Sri Aurobindo Medical College & PG Institute, Indore (M.P.)
  • Vinod Kumar Dhakad Department of Surgical Oncology, Sri Aurobindo Medical College & PG Institute, Indore (M.P.)
  • Simran Behal Department of Pharmacology5, Sri Aurobindo Medical College & PG Institute, Indore (M.P.)

Keywords:

oral tongue cancer, skip metastasis, level IV node, clinically negative neck

Abstract

To identify the rate of positive node / skip metastasis at level IV neck node in early carcinoma tongue after elective neck dissection. The records of fifty two patients were retrospectively reviewed from November 2016 to May 2018who underwent wide excision of tongue lesion with elective neck dissection for early tongue cancer. All the metastatic nodes were at the level from I-III. None of the patient had level IV/V neck node metastasis. Supra omohyoid neck dissection is adequate procedure for node negative early oral tongue cancer patients. The inclusion of level IV dissection should be intraoperative decision and should not be aggressive if no disease was found.

Downloads

Download data is not yet available.

References

NCRPINDIA.2016.PBCR_2012_2014/[ONLINE] Available at http://www.ncrpindia.org.

Ossama Hassan, Mohamed shehata Taha, Hazem El Mehairy. Sentinel lymph node biopsy versus elective neck dissection in evaluation of cN0 neck in patients with oral and oropharyngeal squamous cell carcinoma.Systematic review and meta-analysis study. Egyptian Journal of Ear, Nose, Throat and Allied Sciences 2015;16:25–34

Patel S, Sakthivel P, Singh I, Gulati A,et al. Frequency of skip metastasis in oral cancer: An Overview. Int J Head Neck Surg 2015;6(2):80-85.

D’Cruz A K, Vaish R, Kapre N, Dandekar M, et al. Elective versus therapeutic Neck Dissection in Node-Negative Oral Cancer. N Engl J Med 2015;373:521-9.

Byers RM, Weber RS, Andrews T et al (1997) Frequency and therapeutic implications of ‘‘skip metastases’’ in the neck from squamous carcinoma of the oral tongue. Head Neck 19:14–19.

Balasubramanian D, Thankappan K, BattooAJ,Rajapurkar M, Kuriakose MA, Iyer S. Isolated skip nodal metastasis is rare in T1 and T2 oral tongue squamous cell carcinoma. Otolaryngol Head Neck Surg. 2012;147(2):275-277.

Khafif A, Lopez-Garza JR, Medina JE.Is dissection of level IV necessary in patients with T1-T3 N0 tongue cancer? Laryngoscope. 2001;111 (6):1088-1090.

CS Nithya, Manoj Pandey, BR Naik, Iqbal M Ahamed. Patterns of cervical metastasis from carcinoma of the oral tongue. World Journal of Surgical Oncology 2003; 1:10.

Agarwal SK, Akali NR, Sarin D. Prospective analysis of 231 elective neck dissections in oral squamous cell carcinoma with node negative neck—to decide the extent of neck dissection. AurisNasus Larynx. 2018;45(1):156-161.

Vishak S, Rohan V. Cervical node metastasis in T1 squamous cell carcinoma of oral tongue: pattern and the predictive factors. Indian J SurgOncol. 2014;5(2):104-108.

Mishra P, Sharma AK. A 3-year study of supraomohyoid neck dissection and modified radical neck dissection type I in oral cancer: with special reference to involvement of level IV node metastasis. Eur Arch Otorhinolaryngol. 2010;267 (6):933-938.

Anton Warshavsky, Roni Rosen,Narin Nard-Carmel,Sara Abu-Ghanem,et al. Assessment of the Rate of Skip Metastasis to Neck Level IV in Patients With Clinically Node-Negative Neck Oral Cavity Squamous Cell Carcinoma A Systematic Review and Meta-analysis.JAMAOtolaryngol Head Neck Surg. 2019;145(6):542-548.

Published

26-04-2022

How to Cite

Patidar, H., Pancholi, M., Desai, S., Dhakad, V. K., & Behal, S. (2022). The role of level IV neck dissection in early tongue cancer. International Journal of Health Sciences, 6(S3), 3598–3603. https://doi.org/10.53730/ijhs.v6nS3.6585

Issue

Vol. 6 No. S3 (2022)

Section

Peer Review Articles
Copyright & Licensing

Copyright (c) 2022 International journal of health sciences

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.

Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.

This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.

Crossref
Scopus
Google Scholar
Europe PMC